Epidemiological and clinical features of moyamoya disease in the USA
- PMID: 23445954
- DOI: 10.1159/000345957
Epidemiological and clinical features of moyamoya disease in the USA
Abstract
Background: An increasing number of cases of Moyamoya disease have been reported in the Japanese and US literature. We performed this study to quantify the rise in the prevalence of Moyamoya disease and to study the unique epidemiological and clinical features in the USA that may explain a change in incidence.
Methods: We analyzed data derived from patients entered in the Nationwide Inpatient Sample between 2005 and 2008, using ICD-9 codes for Moyamoya disease. Data including patient age, gender, ethnicity, secondary diagnosis, medical complications, and hospital costs were obtained.
Results: From 2005 to 2008 in the USA, there were an estimated 7,473 patients admitted with a primary or secondary diagnosis of Moyamoya disease. Patients admitted with Moyamoya disease were most frequently women and Caucasian. Overall, ischemic stroke was the most common reason for admission. Hemorrhagic stroke was more frequent in adults compared with children, 18.1 versus 1.5% (p < 0.05).
Conclusion: The number of patients identified and admitted with Moyamoya disease has risen dramatically in the last decade. This study can lead to a better understanding of the disease pattern and healthcare consequences in the USA and suggests that pathophysiologic differences in Moyamoya disease may exist.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
-
Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease.Neurosurgery. 2013 Feb;72(2):210-5; discussion 215. doi: 10.1227/NEU.0b013e31827b9beb. Neurosurgery. 2013. PMID: 23149966
-
Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study.Stroke. 2014 May;45(5):1258-63. doi: 10.1161/STROKEAHA.113.004160. Epub 2014 Mar 27. Stroke. 2014. PMID: 24676775
-
Epidemiological and clinical features of Moyamoya disease in Nanjing, China.Clin Neurol Neurosurg. 2010 Apr;112(3):199-203. doi: 10.1016/j.clineuro.2009.11.009. Epub 2009 Dec 9. Clin Neurol Neurosurg. 2010. PMID: 20004511
-
Moyamoya disease and moyamoya syndrome.N Engl J Med. 2009 Mar 19;360(12):1226-37. doi: 10.1056/NEJMra0804622. N Engl J Med. 2009. PMID: 19297575 Review. No abstract available.
-
Moyamoya-Related Stroke Risk During Pregnancy: An Evidence-Based Reappraisal.World Neurosurg. 2019 Sep;129:e582-e585. doi: 10.1016/j.wneu.2019.05.225. Epub 2019 Jun 6. World Neurosurg. 2019. PMID: 31176061 Review.
Cited by
-
Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease.Transl Stroke Res. 2024 Oct 2. doi: 10.1007/s12975-024-01299-w. Online ahead of print. Transl Stroke Res. 2024. PMID: 39356405
-
Clinical Features and Risk Factors of Postoperative Stroke in Adult Moyamoya Disease.Brain Sci. 2023 Dec 8;13(12):1696. doi: 10.3390/brainsci13121696. Brain Sci. 2023. PMID: 38137144 Free PMC article.
-
Moyamoya Disease: Clinical and Radiological Characteristics in Adult Greek Patients.J Clin Med. 2023 Sep 13;12(18):5951. doi: 10.3390/jcm12185951. J Clin Med. 2023. PMID: 37762892 Free PMC article.
-
Alternative Diagnoses in the Work Up of Down Syndrome Regression Disorder.J Autism Dev Disord. 2023 Aug 16. doi: 10.1007/s10803-023-06057-9. Online ahead of print. J Autism Dev Disord. 2023. PMID: 37584771
-
The Role of Dual Antiplatelet Therapy (DAPT) vs Surgery in a Case of Moyamoya Disease: A Case Report and Review of the Literature.Cureus. 2023 May 30;15(5):e39694. doi: 10.7759/cureus.39694. eCollection 2023 May. Cureus. 2023. PMID: 37398791 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
